Valuation: ScripsAmerica, Inc.

Market Cap 40.98L 35.87L 33.11L 30.89L 58.2L 39Cr 59.24L 3.97Cr 1.54Cr 19Cr 1.54Cr 1.51Cr 67Cr P/E 2013
-0.76x
P/E 2014 -4.13x
Enterprise Value 52.24L 45.72L 42.21L 39.37L 74.18L 49Cr 75.51L 5.06Cr 1.97Cr 24Cr 1.96Cr 1.92Cr 85Cr EV / Sales 2013
2,37,13,364x
EV / Sales 2014 7,67,004x
Free-Float
97.92%
Yield 2013 *
-
Yield 2014 -
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
Manager TitleAgeSince
Chief Executive Officer - 30/06/2015
Director TitleAgeSince
Chairman - 30/06/2015
Director/Board Member 50 26/03/2015
Director/Board Member 50 19/07/2016
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 141
-3.18%-1.08%-23.63%-33.59% 1.34TCr
-3.14%-6.10%-35.02%-34.61% 634.88Cr
-3.41%-1.86%-21.85%-14.61% 581.09Cr
-4.77%-8.08%-26.52%-41.69% 320.91Cr
-0.75%-1.57%-38.69%-12.94% 324.4Cr
+0.65%-1.27%-27.29%-45.13% 321.8Cr
-2.91%-6.00%-7.79%-46.34% 251.99Cr
+3.54%+6.84%+96.48% - 265.12Cr
-1.38%-0.56%-18.91%-6.58% 245.19Cr
Average -1.55%-1.20%-11.47%-29.44% 428.32Cr
Weighted average by Cap. -2.33%-1.36%-18.07%-30.06%

Financials

2013 2014
Net sales 0.56 0.49 0.45 0.42 0.79 52.59 0.8 5.39 2.09 25.95 2.09 2.04 90.41 30.85 27.01 24.93 23.26 43.82 2.92T 44.6 299.04 116.1 1.44T 115.92 113.33 5.02T
Net income -1.12Cr -97.99L -90.46L -84.38L -1.59Cr -105.85Cr -1.62Cr -11Cr -4.21Cr -52Cr -4.21Cr -4.11Cr -181.97Cr -47.31L -41.41L -38.23L -35.66L -67.19L -45Cr -68.39L -4.59Cr -1.78Cr -22Cr -1.78Cr -1.74Cr -77Cr
Net Debt 24.82L 21.72L 20.05L 18.7L 35.24L 23Cr 35.87L 2.41Cr 93.38L 12Cr 93.23L 91.15L 40Cr 11.26L 10L 9L 8L 15.99L 11Cr 16.27L 1.09Cr 42.35L 5.25Cr 42.29L 41.35L 18Cr
Logo ScripsAmerica, Inc.
ScripsAmerica, Inc. is engaged in the distribution of prescription and over the counter pharmaceuticals. The Company's subsidiaries include Main Avenue Pharmacy Inc. (Main Avenue), DispenseDoc Inc. (DispenseDoc) and Pharmacy Administration, Inc. (Pharmacy Administration). It also holds interests in P.I.M.D. International LLC (PIMD). Its operations consist of the sale and compounding of non-sterile topical and transdermal pain creams through Main Avenue; wholesale sales to independent pharmacies and other medical providers through PIMD; pharmacy dispensing services for individual doctors through DispenseDoc, and billing and administrative services through Pharmacy Administration. Main Avenue's prescription pain creams incorporate approximately eight active pharmaceutical ingredients for application on the skin and in localized areas. As of December 31, 2014, PIMD held licenses in over 20 states to receive, store and ship Schedule 3 through Schedule 5 formulary pharmaceuticals.
Employees
-
  1. Stock Market
  2. Stocks
  3. SCRCQ Stock